viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 129
tüüp :
ajaleht
uurimisrühmad :
Royal Oak - William Beaumont Hospital, Department of Pharmacy
Autor :
Smythe M, Malouf E.
pealkiri :
Visual compatibility of insulin with secondary intravenous drugs in admixtures.
publikatsioon :
Am J Hosp Pharm ; 48: 125-126. 1991
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Ampicillin sodium
20 mg/ml
+
Insulin
0.2 UI/ml
+
Ampicillin sodium - sulbactam sodium
30 mg/ml
+
Insulin
0.2 UI/ml
+
Aztreonam
20 mg/ml
+
Insulin
0.2 UI/ml
+
Cefazolin sodium
20 mg/ml
+
Insulin
0.2 UI/ml
+
Gentamicin sulfate
1.2 >> 2 mg/ml
+
Insulin
0.2 UI/ml
+
Heparin sodium
60 UI/ml
+
Insulin
0.2 UI/ml
+
Insulin
0.2 UI/ml
+
Ampicillin sodium
20 mg/ml
+
0.2 UI/ml
+
Ampicillin sodium - sulbactam sodium
30 mg/ml
+
0.2 UI/ml
+
Aztreonam
20 mg/ml
+
0.2 UI/ml
+
Cefazolin sodium
20 mg/ml
+
0.2 UI/ml
+
Gentamicin sulfate
1.2 >> 2 mg/ml
+
0.2 UI/ml
+
Heparin sodium
60 UI/ml
+
0.2 UI/ml
+
Magnesium sulfate
40 mg/ml
+
0.2 UI/ml
+
Morphine sulfate
5 mg/ml
+
0.2 UI/ml
+
Nafcillin sodium
20 & 40 mg/ml
+
0.2 UI/ml
+
Oxytocin
0.02 UI/ml
+
0.2 UI/ml
+
Pethidine hydrochloride
50 mg/ml
+
0.2 UI/ml
+
Terbutaline sulfate
0.02 mg/ml
+
0.2 UI/ml
+
Ticarcillin / clavulanic acid
31 mg/ml
+
0.2 UI/ml
+
Tobramycin sulfate
1.6 & 2 mg/ml
+
0.2 UI/ml
+
Vancomycin hydrochloride
4 mg/ml
+
Magnesium sulfate
40 mg/ml
+
Insulin
0.2 UI/ml
+
Morphine sulfate
5 mg/ml
+
Insulin
0.2 UI/ml
+
Nafcillin sodium
20 & 40 mg/ml
+
Insulin
0.2 UI/ml
+
Oxytocin
0.02 UI/ml
+
Insulin
0.2 UI/ml
+
Pethidine hydrochloride
50 mg/ml
+
Insulin
0.2 UI/ml
+
Terbutaline sulfate
0.02 mg/ml
+
Insulin
0.2 UI/ml
+
Ticarcillin / clavulanic acid
31 mg/ml
+
Insulin
0.2 UI/ml
+
Tobramycin sulfate
1.6 & 2 mg/ml
+
Insulin
0.2 UI/ml
+
Vancomycin hydrochloride
4 mg/ml
+
Insulin
0.2 UI/ml
+
Mentions Légales
